Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
Metabolic dysfunction-associated fatty liver disease and long-term kidney function decline: a 16-year population-based cohort study
Related
- Inflammation-Related Biomarkers Linking Environmental Chemical Mixtures and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Population-Based Study from NHANES 1999-2020
- Association of the nutritional metabolic risk index with metabolic dysfunction-associated steatotic liver disease in a sub-plateau population
- Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) : A systematic review and meta-analysis
- Efficacy of plant extracts for metabolic dysfunction-associated steatotic liver disease: a network meta-analysis
- Tirzepatide use in adolescents with metabolic dysfunction‐associated steatotic liver disease (MASLD): A case series
BibTeX
@article{kim2026metabolic,
title = {{Metabolic dysfunction-associated fatty liver disease and long-term kidney function decline: a 16-year population-based cohort study}},
author = {Woogyeom Kim and Hyeon Woo and Dae Hyeon Cho and Jaeuk Shin and Yu-Ji Lee},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-75727-2},
url = {https://www.nature.com/articles/s41598-026-75727-2},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Metabolic dysfunction-associated fatty liver disease and long-term kidney function decline: a 16-year population-based cohort study
AU - Woogyeom Kim
AU - Hyeon Woo
AU - Dae Hyeon Cho
AU - Jaeuk Shin
AU - Yu-Ji Lee
PY - 2026
DA - 2026/10/12
JO - Scientific Reports
DO - 10.1038/s41598-026-75727-2
UR - https://www.nature.com/articles/s41598-026-75727-2
SN - 2045-2322
ER -